after 1 and 4 years of treatment , 18 % and 42 % of the patients treated with mexiletine alone had died suddenly or suffered recurrent symptomatic vt , compared to 11 % and 25 % of patients treated with the combined antiarrhythmic drug regimens ( p = ns ) .
C0025887
mexiletine
C0003195
antiarrhythmic drug